Where does Novastep rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Novastep ranks #26,999 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Novastep hold?

Novastep holds 10 US utility patents granted between 2016 and 2024, spanning 5 technology areas.

What is Novastep's Innovation Score?

Novastep has an Innovation Score of 32.6 out of 100 (42nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Novastep focus on?

Novastep's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 7 patents, ranking #2,341 of 7,127 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Novastep's patent grant rate increasing or decreasing?

Novastep's recent grant velocity is +300% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Novastep's patents?

Novastep's patents average 8.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Novastep patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Novastep

USPTO PatentsView assignee record - 10 granted patents across 5 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Novastep ranks #26,999 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 5 technology areas.

#26,999
of 49,997 US assignees by volume: 42nd percentile
by Innovation Score (32.6/100): 8.8
avg claims per patent: +300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26999 · Foreign Corporation #26,999 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,999/49,997
PHOTO-FINISH Noke
CPC-NARROW A61B · 5 areas
INNOV-THIN 32.6/100
CLAIMS-PAR 8.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +300% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Noke, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Novastep’s 32.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (25%) Velocity 11.1 pts (34%) Breadth 7.9 pts (24%) Claim depth 5.3 pts (16%)

Qualcomm Incorporated · highest

85
Abaxis · near

33
DynaEnergetics & KG · near

33
Novastep · this assignee

33
Tong Lung Metal… · near

33
VCE · near

33
3D Lighting… · lowest

7

What this shows Novastep's Innovation Score is 32.6/100 (42nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Novastep?

Each dot is one of Novastep’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Novastep’s own 8.8 claims/patent is at or below the 14.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Novastep vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Novastep's grants concentrate

Novastep is a focused PatentsView assignee: 5 CPC subclasses with 70% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2016. By volume, Novastep sits between Noke, Inc. and Nsfocus Technologies, Inc..

Novastep's three-year grant acceleration

Novastep shows 5 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Noke

10
North & South Bro…

10
Novabiotics

10
Novabone Products

10
Novatron OY

10
Novenco A/S

10
Novoxel

10
Nsfocus

10
Novastep ◀

10

What this shows Novastep holds 10 patents at rank #26,947, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Novastep

By rank, the assignees closest to #26,947 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Novastep's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Novastep, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Novastep ranks #2,341 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (33 here).

Abaxis, Inc. 33 VCE Company, LLC 33 DynaEnergetics GmbH & Co. KG 33 Tong Lung Metal Industry Co., Ltd. 33

Novastep's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 42nd percentile higher than 42% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Novastep patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	10.0%
2018	1	10.0%
2020	1	10.0%
2021	2	20.0%
2023	2	20.0%
2024	3	30.0%

Which technologies does Novastep patent most?

A61B - DIAGNOSIS; SURGERY; Identification 7

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

A61C - DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene 1

B25G - Handles FOR Hand Implements 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Novastep's patent record in context - here's where to go next.

Novastep's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 70% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #26,999 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Novastep against Noke, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.